• RepSox and the Next Frontier of hiPSC Platelet Science

  2026-09-15

  A mechanistic and translational perspective on how RepSox, a potent and selective ALK5 inhibitor, could help researchers interrogate TGF-β signaling during induced pluripotent stem cell reprogramming and platelet differentiation. The article connects recent hiPSC platelet-production advances with practical assay design, competitive strategy, and the limitations that must be resolved before RepSox can be positioned within a manufacturing workflow.

• Leonurine, STING, and Doxorubicin Cardiotoxicity

  2026-09-14

  This Advanced Science study identifies cardiac vascular endothelial cells as early sensors and amplifiers of doxorubicin cardiotoxicity, linking endothelial cGAS–STING activation to NLRP3-mediated pyroptosis, pathogenic extracellular vesicles, and cardiomyocyte mitochondrial injury. It further presents leonurine as a direct STING inhibitor that binds TYR261, suggesting an endothelial-centered therapeutic strategy rather than a cardiomyocyte-only approach.

• Lysis Buffer: From Mouse DNA to Model Quality

  2026-09-14

  Explore how lysis buffer supports genomic DNA release from mouse tail samples and why pre-analytical control matters for mouse genotyping. This evidence-led guide connects rapid tissue processing with the assay-design lessons of a multi-omics colorectal cancer study.

• Oseltamivir acid: Research Workflows & Troubleshooting

  2026-09-13

  Oseltamivir acid supports orthogonal influenza neuraminidase, cell-based replication, resistance, and oncology assays without requiring prodrug activation in the test system. This workflow-focused guide connects practical compound handling with humanized-mouse pharmacokinetic principles while separating established evidence from optimization starting points.

• Idoxuridine: Viral DNA Synthesis Workflow

  2026-09-12

  Build a reproducible viral replication assay around Idoxuridine, from DMSO stock preparation to orthogonal DNA and viability readouts. The workflow emphasizes mechanism-aligned controls, practical troubleshooting, and a careful translation of human-neuron assay principles without overstating antiviral evidence.

• ddATP Workflows for DNA Synthesis Termination

  2026-09-11

  ddATP gives researchers a tunable way to terminate DNA synthesis at adenine-directed incorporation sites, supporting sequencing, polymerase profiling, and DNA damage studies. This guide connects practical assay design with evidence from a mouse-oocyte break-induced replication model while distinguishing validated findings from workflow starting points.

• Resiniferatoxin (RTX): TRPV1 Pain Research

  2026-09-11

  Resiniferatoxin (RTX) is an ultra-potent TRPV1 agonist that produces sustained calcium entry followed by functional sensory-neuron desensitization. Its strongest research value is as a selective tool for pain, neurogenic inflammation, and route-specific analgesia models rather than as a general anti-inflammatory compound.

• Annexin V: Reading Phosphatidylserine Signals

  2026-09-10

  Annexin V is a calcium-dependent phosphatidylserine binding protein for interpreting membrane-state changes in apoptosis assays. This mechanistic guide explains how recombinant Annexin V, structural purification insight, and orthogonal controls can improve cell death research and cancer research workflows.

• Ibrutinib, CSK Inhibition, and Atrial Fibrillation

  2026-09-10

  This study combines mouse electrophysiology, chemoproteomics, genetic models, and pharmacovigilance to identify C-terminal Src kinase (CSK) inhibition as the likely mechanism of ibrutinib-associated atrial fibrillation. Its findings distinguish an off-target cardiac liability from Bruton tyrosine kinase inhibition and provide a framework for evaluating kinase-inhibitor selectivity and safety.

• BOP Reagent: From Coupling to Assay-Ready Prodrugs

  2026-09-09

  Explore how BOP reagent supports carboxyl group activation, phenyl ester preparation, and amide bond formation while improving the analytical handoff from synthesis to prodrug assays. A focused case study connects coupling chemistry with ROS-responsive triterpene research in oral squamous cell carcinoma.

• SP1/ADAM10/DRP1 Signaling in Hypoxic Pulmonary Hypertension

  2026-09-09

  The reference study identifies a hypoxia-responsive SP1/ADAM10/DRP1 signaling axis that connects endothelial-cell activity with smooth-muscle-cell remodeling in hypoxia pulmonary hypertension. Its conditioned-medium experiments further implicate PI3K/AKT/mTOR signaling, providing a mechanistic framework for studying endothelial–smooth muscle crosstalk and potential intervention points.

• Nadolol (SQ-11725) Research Workflow Guide

  2026-09-09

  Nadolol (SQ-11725) enables paired studies of non-selective beta-adrenergic blockade and transporter-aware pharmacokinetics. This guide translates recent tissue-distribution research into practical workflows for hypertension research, angina pectoris studies, and vascular headache research.

• Phenytoin and Human Serum Paraoxonase-1 Inhibition

  2026-09-08

  The reference study examines how five antiepileptic drugs inhibit purified human serum paraoxonase-1, extending AED research beyond neuronal targets to a clinically relevant antioxidant enzyme. Phenytoin inhibited hPON1 less strongly than gabapentin, valproic acid, and primidone but more strongly than levetiracetam, providing a biochemical hypothesis for future drug–enzyme and oxidative-stress studies.

• Temafloxacin Combinations Against Mycobacterium avium

  2026-09-07

  This 1993 study evaluated clarithromycin, Temafloxacin, and ethambutol against pigmented and non-pigmented Mycobacterium avium complex strains using extracellular susceptibility, drug-interaction, and macrophage infection assays. Its central finding was that combination treatment, particularly the three-drug regimen in the intracellular model, produced more informative activity than assessment of individual agents alone.

• IGF2BP1–TUBB4B Signaling in Liver Fibrosis

  2026-09-07

  The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its integrated transcriptomic and cellular approach provides a mechanistic framework for studying RNA stability in fibrogenesis while clarifying the distinction between validated findings and future methylation-pathway experiments.

8315 records 1/555 page Next 12345 下5页 Last page